Estar Medical strives to enrich the product portfolio by constantly investing in R&D. Our efforts continue to yield highly promising data and new intellectual property across a range of therapeutic areas.
The product pipeline is based on our unique Tropocells® System Platform and consists of the following products:
- Novel PRP-based regenerative products combining PRP with a range of clinically & commercially valuable biologics, such as hyaluronic acid, collagen, bone substitutes
- BMAC System for concentrating bone marrow aspirate-derived cells
- Tropokine™ - System for autologous IL1-RA enrichment
- Autologous biological glues
- Autologous thrombin
- PRP combined with other biologics